CHOROIDAL THICKNESS CHANGE AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN RETINAL ANGIOMATOUS PROLIFERATION AND ITS RECURRENCE. [electronic resource]
Producer: 20170308Description: 1516-26 p. digitalISSN:- 1539-2864
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Bevacizumab -- therapeutic use
- Choroid -- diagnostic imaging
- Choroid Diseases -- diagnosis
- Female
- Fluorescein Angiography
- Humans
- Intravitreal Injections
- Macular Degeneration -- diagnosis
- Male
- Ophthalmoscopy
- Organ Size
- Ranibizumab -- therapeutic use
- Recurrence
- Retinal Neovascularization -- diagnosis
- Retreatment
- Retrospective Studies
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.